Clinical Trial Update: STP.168 Clinical Study Protocol Parakeet [NA]

View source ↗

Summary

A protocol update for STP.168 Parakeet by Neurovision Medical Products on parathyroid conditions; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism
• Parathyroid Adenoma
• Parathyroid Disorders

Drugs mentioned

• Parakeet (STP.168)

Snippet

Sponsor: Neurovision Medical Products Inc | Conditions: Parathyroid; Anomaly, Parathyroid Dysfunction | NA | Status: ACTIVE_NOT_RECRUITING